Prognostic Factors in Hodgkin Lymphoma
Hodgkin lymphoma (HL) is among the neoplastic diseases that has the best long-term outcome after cytotoxic treatment. Cure rates approach 80–90%; however, 15–20% of patients will be resistant to therapy (primary refractory) or relapse after treatment. Prognostic factors should help to stratify treat...
| Main Authors: | , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Università Cattolica del Sacro Cuore
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4103502/ |